About this trial
The PPOS protocol (Progestin-primed Ovarian Stimulation) involves avoiding ovulation during ovarian stimulation with progesterone. It is a reliable and safe protocol that has been widely used in recent years for in vitro fertilization, as it reduces the number of injections needed during controlled ovarian stimulation and is more cost-effective for patients.
The aim of this study is to compare two methods of ovarian stimulation for in vitro fertilization: the PPOS protocol (Group A) and the conventional protocol with injected antagonists (Group B). The goal is to determine whether both methods are equally effective in obtaining euploid embryos in the context of double ovarian stimulation.
Eligibility criteria
Qualifiers
Regular menstrual cycles between 21 and 35 days, inclusive.
Indication of IVF with PGT-A.
Both ovaries present.
Ability to participate and complete the study.
Disqualifiers
Endometriosis grade III/IV
Concurrent participation in another study
Trial design
Treatments tested in this trial
- Ganirelix
- Medroxyprogesterone Acetate 10 MG
Treatment groups
Locations
Sponsors and collaborators
Ginefiv
Lead sponsor
Theramex
Collaborator